|
|
||||||||
Ann Thorac Surg 2001;72:S1806-S1807
© 2001 The Society of Thoracic Surgeons
a Department of Anesthesia, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
* Address reprint requests to Dr Ellison, Department of Anesthesia, Hospital of the University of Pennsylvania, 3400 Spruce St, 413 Ravdin Courtyard, Philadelphia, PA 19104, USA
e-mail: ellisonn{at}uphs.upenn.edu
Presented at Mechanisms and Attenuation of Abnormalities in Hemostasis/Inflammation and Neurologic Injury: Implications for Patient Outcomes, Vancouver, BC, Canada, May 6, 2001.
The value of red blood cell administration to increase oxygen carrying capacity is obvious to all clinicians. Nevertheless, there has never been a prospective, randomized, controlled study documenting the efficacy or conclusively defining the indications for red blood cell use. Considering the risks associated with allogeneic blood, careful consideration must be given before the administration of each unit of blood product.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |